Dividend compounder review
VCYT
Veracyte Inc · NASDAQ · US
Healthcare · Diagnostics & Research
Score51.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Quality breakdown
Dividend Reliability
0.0 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
14.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
21.5 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
3.5 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
12.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$66.4M
Free Cash Flow$126.6M
FCF Covers DividendUnknown
Debt / Equity2.93
P/E43.8
Revenue Growth 5Y34.5%
Net Margin16.2%
ROE6.9%
Price vs Trend21.0%
3Y Return85.4%
5Y Return12.7%
CurrencyUSD
Review flags
No usable dividend history found.
Debt to equity is elevated at 2.93.
Activity record
Debt to equity is elevated at 2.93.